LBPH — Longboard Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Longboard Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview
Longboard Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Longboard Pharmaceuticals Provides Corporate Update And Reports Second Quarter 2022 Financial Results
Longboard Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Longboard Pharmaceuticals Provides Corporate Update And Reports First Quarter 2022 Financial Results
Brief: Longboard Pharmaceuticals Posts FY Net Loss Of $27.8 Mln
U.S. STOCKS ON THE MOVE-Ford, Splash Beverage, semiconductor stocks, U.S. Bancorp
Zogenix soars on UCB's $1.46 billion acquisition
Brief: Longboard Pharmaceuticals Inc, On November 15, Increased Size Of Board From Six Directors To Seven Directors
Brief: Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller To Board Of Directors
Brief: Longboard Pharma Reports Third Quarter 2021 Financial Results
Brief: Longboard Pharmaceuticals Announces Steven W. Spector Joins The Company As General Counsel
Brief: Longboard Pharmaceuticals Successfully Completes Lp352 Multiple Ascending Dose Portion Of Phase 1 Clinical Trial In Healthy Volunteers, Plans To Initiate Phase 1B/2A Clinical Trial
Brief: Longboard Pharmaceuticals Reports Q2 Results
Longboard Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Longboard Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Longboard Pharmaceuticals Reports Qtrly Loss Per Share Of 84 Cents
U.S. RESEARCH ROUNDUP-Alliance Data Systems, Mr.Cooper Group, Pennymac Financial Services